Scidera, Inc. v Meat and Livestock Australia Limited

Link copied
Case Copied 80 min read

FEDERAL COURT OF AUSTRALIA

Scidera, Inc. v Meat and Livestock Australia Limited [2025] FCA 308

File number: VID 1007 of 2023
Judgment of: ROFE J
Date of judgment: 7 April 2025
Catchwords: PRACTICE AND PROCEDURE – application to strike out statement of claim – whether pleading or parts of the pleading are ambiguous, likely to cause prejudice, embarrassment or delay, or fail to disclose a reasonable cause of action – whether the pleading fails to comply with rr 16.21 and 34.42 of the Federal Court Rules 2011 (Cth)
Legislation:

Federal Court of Australia Act 1976 (Cth)

Patents Act 1990 (Cth)

Taxation Administration Act 1953 (Cth)

Federal Court Rules 2011 (Cth)

Cases cited:

Ariosa Diagnostics, Inc v Sequenom, Inc (2021) 159 IPR 371

Australian Competition and Consumer Commission v Pauls Ltd [1999] FCA 1750

Australian Mud Co Pty Ltd v Globaltech Corporation Pty Ltd (No 3) (2022) 169 IPR 1

Banque Commerciale SA (En Liquidation) v Akhil Holdings Ltd (1990) 169 CLR 279

Barclay Mowlem Construction Ltd v Dampier Port Authority (2006) 33 WAR 82

Commissioner of Taxation v White (No 2) [2024] FCA 1291

Dare v Pulham (1982) 148 CLR 658

EIX20 v State of Western Australia [2022] FCA 1357

Forrest v Australian Securities and Investments Commission (2012) 247 CLR 486

Gall v Domino's Pizza Enterprises Ltd (No 2) (2021) 391 ALR 675

KTC v David [2022] FCAFC 60

Magman International Pty Ltd v Westpac Banking Corporation (1991) 32 FCR 1

Meat and Livestock Australia v Cargill, Inc (2018) 129 IPR 278

Meat and Livestock Australia v Cargill, Inc (No 2) (2019) 139 IPR 47

Murdock v Virgin Australia Airlines Pty Ltd (No 2) [2023] FCA 569

Nomura International Plc v Granada Group Ltd [2007] EWHC 642

Oztech Pty Ltd v Public Trustee of Queensland (2019) 269 FCR 349

Polar Aviation Pty Ltd v Civil Aviation Safety Authority (2012) 203 FCR 325

Seiko Epson Corporation v Calidad Pty Ltd (2017) 133 IPR 1

Sequenom, Inc. v Ariosa Diagnostics, Inc. (2019) 143 IPR 24

Stone(liquidator), in the matter of Ironbark Blacksmithing Pty Ltd (in liq) v Mizzi [2024] FCA 696

Thomson v STX Pan Ocean Co Ltd [2012] FCAFC 15

Trade Practices Commission v Pioneer Concrete (Qld) Pty Ltd (1994) 52 FCR 164

Upaid Systems Ltd v Telstra Corp Ltd (2013) 220 FCR 182

Wardley Australia Ltd v Western Australia (1992) 175 CLR 514

Wride v Shulz [2004] FCAFC 216

Division: General Division
Registry: Victoria
National Practice Area: Intellectual Property
Sub-area: Patents and associated Statutes
Number of paragraphs: 219
Date of last submissions: 21 August 2024
Date of hearing: 16 September 2024
Counsel for the Applicant: C Dimitriadis SC, M Evetts
Solicitor for the Applicant: K&L Gates
Counsel for the First Respondent: C Cunliffe
Solicitor for the First Respondent: King & Wood Mallesons
Counsel for the Second Respondent: K Beattie SC
Solicitor for the Second Respondent: Norton Rose Fulbright
Counsel for the Third Respondent: P Flynn SC, B Mee
Solicitor for the Third Respondent: Allens
Counsel for the…
CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Scidera, Inc. v Meat and Livestock Australia Limited and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2025] FCA 308
Decision Date

CaseChat Overview and Summary

Scidera, Inc. initiated a patent infringement case against Meat and Livestock Australia Limited and others, concerning a method or system for identifying bovine traits from nucleic acid samples. The case is at an early stage, with no defences filed, no discovery conducted, and no evidence presented. The third respondent, Zoetis, filed an affidavit as an example of the evidence to be presented. The matter involves the interpretation and infringement of claims related to a patent, Australian Standard Patent No. 2010202253, which has a history of opposition and appeal proceedings. Scidera alleges direct infringement by Zoetis and others, who are genomic testing laboratories providing services in Australia. The respondents filed applications to strike out parts of the statement of claim on the grounds of ambiguity, potential prejudice, and non-compliance with Federal Court Rules.

The court was required to determine whether the pleadings were ambiguous, likely to cause prejudice, or failed to disclose a reasonable cause of action, and whether they complied with the relevant Federal Court Rules. Additionally, the court had to consider whether the pleadings provided sufficient detail for the respondents to prepare their defences without the need for discovery.

The court found that the amended statement of claim (ASOC) sufficiently detailed each instance of alleged infringement, thus satisfying the basic functions of pleadings. The court acknowledged the less strict approach to pleadings in modern case management, emphasising the use of pre-trial disclosure and interventionist case management. The court noted that the respondents, being sophisticated litigants, were adequately apprised of the claims against them. The court dismissed the respondents' applications to strike out the pleadings, allowing the filing of the ASOC with necessary amendments. The court ordered that the applicant pay the respondents' costs for the first hearing and that the parties' costs for the amendments and the 16 September 2024 hearing be costs in the cause. The matter was listed for a case management hearing on the week of 14 April 2025.

Orders

Orders of the court

1. The interlocutory applications dated 19 April 2024 filed by the first respondent, second respondent, third respondent and fifth respondent are dismissed.

2. The applicant has leave to file an amended statement of claim substantially in the form annexed to my reasons, subject to amendments which I have indicated are necessary.

3. Once the amended statement of claim is filed, Genotyping Australia Pty Ltd ACN 632 605 817 trading as Xytovet be joined as the sixth respondent in this proceeding.

4. The applicant pay the respondents’ costs thrown away by reason of the 9 May 2024 hearing.

5. The parties’ costs of and incidental to the proposed amendments to the statement of claim and the 16 September 2024 hearing be costs in the cause.

6. The proceeding be listed for a case management hearing on the week of 14 April 2025.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

The third respondent, Zoetis, filed an affidavit of Mr Frederick Schwenke, Zoetis’s Director — Livestock Business Unit, made on 10 September 2024. The document was tendered, not for the truth of its contents, but as an example of the type of evidence that would be filed by Zoetis in the proceeding.2. Background This proceeding is a patent infringement case which relates broadly to the use of a method or system to identify or infer a trait of a bovine subject from a nucleic acid sample of the bovine subject, comprising identifying in the nucleic acid sample an occurrence of at least three single nucleotide polymorphisms (SNPs) wherein each of the at least three SNPs satisfies particular requirements identified in the claims in suit. Scidera is the patentee of the patent in suit: Australian Standard Patent No. 2010202253 (Patent). The proceeding is at an early stage. No defences have been filed. There has been no discovery and no evidence has been filed.2.1 Patent history The patent application, which became the Patent in suit, was the subject of pre-grant opposition proceedings involving MLA and the former fourth respondent to this proceeding, Dairy Australia. Justice Beach published two judgments regarding those proceedings in which the patent application (which on grant became the Patent), the relevant technical background, the construction of the claims and a range of other issues were considered: Meat and Livestock Australia v Cargill, Inc (2018) 129 IPR 278; Meat and Livestock Australia v Cargill, Inc (No 2) (2019) 139 IPR 47. 2.1.1ASOC structure Paragraphs [1] to [6A] identify the parties. [6A] introduces the proposed sixth respondent, the second genomic testing laboratory, Xytovet. Paragraphs [7] to [21A] plead the Patent and its term, and the relevant background to the Patent, being the opposition, the parties to the opposition, the appeal from the opposition, and the amendment of the patent application. Part II of the ASOC relates to the “Beef Cohort Claims”, starting at [22] and finishing at [74]. The allegations of infringement against MLA and ABRI are found in the Beef Cohort Claims section of the ASOC. Part III of the ASOC relates to the “Dairy Cohort Claims”, starting at [75] and continuing to [121]. The allegations against DataGene are found in the Dairy Cohort Claims. Both the Beef Cohort Claims and the Dairy Cohort Claims follow the same pattern of pleading. Both cohorts are applicable to Zoetis and Xytovet.2.2 Scidera’s allegations Scidera makes a direct infringement claim against Zoetis (and the proposed sixth respondent, Xytovet). Zoetis is one of two genomic testing laboratories which is alleged in the ASOC to have provided genomic selection services in Australia for identifying bovine traits of economic interest in beef and dairy cattle, using high density SNP chips to perform SNP testing of genetic material. Zoetis and Xytovet are alleged to have provided those genomic selection services in a manner compatible with the systems provided or promoted by the remaining respondents as discussed below.

Evidence

Evidence Before The Court

Decision

Reasons for decision

The pleading of infringement of the claims in the ASOC is more than an “overarching allegation of infringement of certain claims” referable to “generally described acts” with more details to be provided after discovery. There is sufficient detail of each instance of infringement alleged that it will be clear if Scidera were either to seek discovery in relation to broader (unpleaded) instances of infringement, or if it were successful on liability, to seek relief in relation to such broader instances.7. Conclusion For the reasons above, the respondents’ respective strike out Applications are dismissed. Notwithstanding, the Court acknowledges that in the face of these Applications, Scidera filed the Response and Further Particulars and then, sought to amend its SOC in to the form of the draft ASOC, which is the subject of this judgment. I will allow for the ASOC to be filed, subject to any amendments which I have indicated are necessary. In relation to the hearing of 9 May 2024, I consider that the applicant should pay the respondents’ costs thrown away in relation to the first hearing. In relation to the 16 September 2024 hearing of the Applications, the parties’ costs be costs in the cause. I will order that the matter be listed for a case management hearing on the week of 14 April 2025.

Ratio Decidendi

Legal Principle Established

Further, DataGene asserts that it is not clear what difference, if any, there is between the infringement claim made against DataGene acting together with Xytovet or Zoetis and the indirect infringement claim that DataGene has induced, procured or engaged in a common design with Xytovet or Zoetis to infringe the Patent. With respect to this point, Scidera contends that the fact that there is overlap between these allegations against DataGene is not a basis for striking out the pleading. 6. Consideration The deficiencies identified in the SOC at the first return have largely been dealt with by the amendments embodied in the ASOC. The references to the conduct of other genomic testing laboratories who were not parties to the proceeding have been removed. Before dealing with the specific matters raised by the respondents on this occasion, I will make some general comments about the use of pleadings in the context of contemporary case management and s 37M of the FCA Act. Justice Murphy in Gall v Domino’s Pizza Enterprises Ltd (No 2) (2021) 391 ALR 675 observed at [19] that in modern times courts have often taken a “less strict approach” to the application of pleadings principles, and have preferred to use pre-trial disclosure of evidence and exchange of submissions and interventionist case management techniques to address some of the difficulties sometimes associated with pleadings. His Honour noted that he broadly agreed with the approach of Martin CJ in Barclay Mowlem at [4] to [7] (as set out above). As Martin CJ noted at [7] in Barclay Mowlem: … provided a pleading fulfils its basic functions of identifying the issues, disclosing an arguable cause of action or defence, as the case may be, and apprising the parties of the case that has to be met, the court ought properly be reluctant to allow the time and resources of the parties and the limited resources of the court to be spent extensively debating the application of technical pleadings rules that evolved in and derive from a very different case management environment. The parties to this proceeding are sophisticated litigants with legal advisers experienced in patent litigation. MLA also has had the benefit of being the moving opponent in the previous opposition and appeal therefrom. The other respondents also have the benefit of Beach J’s extensive reasons on the appeal from the opposition and the amendment application in Cargill and Cargill (No 2). After the oral and written ventilation of the respondents’ concerns and the detailed explanation of the ASOC structure and allegations provided by the applicant’s senior counsel at the hearing, it would be difficult to see how the respondents could say they were not sufficiently apprised of the case that is to be put against each of them for the purposes of preparing their respective defences. By the time they are required to put on evidence, the respondents will also have the benefit of the applicant’s evidence. I now turn to the substantive concerns raised by the respondents.6.1 Multiple constructions